204 related articles for article (PubMed ID: 32029851)
1. Production and control of coagulation proteins for factor X activation in human endothelial cells and fibroblasts.
Cohen CT; Turner NA; Moake JL
Sci Rep; 2020 Feb; 10(1):2005. PubMed ID: 32029851
[TBL] [Abstract][Full Text] [Related]
2. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
[TBL] [Abstract][Full Text] [Related]
4. Human endothelial cells and fibroblasts express and produce the coagulation proteins necessary for thrombin generation.
Cohen CT; Turner NA; Moake JL
Sci Rep; 2021 Nov; 11(1):21852. PubMed ID: 34750441
[TBL] [Abstract][Full Text] [Related]
5. Blood coagulation factors in human embryonic-fetal development: preferential expression of the FVII/tissue factor pathway.
Hassan HJ; Leonardi A; Chelucci C; Mattia G; Macioce G; Guerriero R; Russo G; Mannucci PM; Peschle C
Blood; 1990 Sep; 76(6):1158-64. PubMed ID: 1698100
[TBL] [Abstract][Full Text] [Related]
6. Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitution in factor IX.
Ndonwi M; Broze GJ; Agah S; Schmidt AE; Bajaj SP
J Biol Chem; 2007 May; 282(21):15632-44. PubMed ID: 17387172
[TBL] [Abstract][Full Text] [Related]
7. Activation of bovine factor IX by the reaction product of bovine factor VII and human tissue factor.
Liu DY; Rosen S
Chin Med J (Engl); 1994 Mar; 107(3):181-5. PubMed ID: 8088177
[TBL] [Abstract][Full Text] [Related]
8. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Nielsen VG; Cohen BM; Cohen E
Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
[TBL] [Abstract][Full Text] [Related]
9. Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors.
Topcuoglu P; Arat M; Dalva K; Ozcan M
Bone Marrow Transplant; 2004 Jan; 33(2):171-6. PubMed ID: 14647251
[TBL] [Abstract][Full Text] [Related]
10. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
[TBL] [Abstract][Full Text] [Related]
11. Characterization of porcine factor VII, X and comparison with human factor VII, X.
Chen Y; Qiao J; Tan W; Lu Y; Qin S; Zhang J; Li S; Bu H; Cheng J
Blood Cells Mol Dis; 2009; 43(1):111-8. PubMed ID: 19286401
[TBL] [Abstract][Full Text] [Related]
12. Basic mechanisms in blood coagulation.
Davie EW; Fujikawa K
Annu Rev Biochem; 1975; 44():799-829. PubMed ID: 237463
[No Abstract] [Full Text] [Related]
13. Extrahepatic synthesis of factor VII in human atherosclerotic vessels.
Wilcox JN; Noguchi S; Casanova J
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):136-41. PubMed ID: 12524237
[TBL] [Abstract][Full Text] [Related]
14. Impaired human tissue factor-mediated activity in blood clotting factor VIINagoya (Arg304-->Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor.
Matsushita T; Kojima T; Emi N; Takahashi I; Saito H
J Biol Chem; 1994 Mar; 269(10):7355-63. PubMed ID: 8125953
[TBL] [Abstract][Full Text] [Related]
15. A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates.
Toso R; Pinotti M; High KA; Pollak ES; Bernardi F
Biochem J; 2002 Apr; 363(Pt 2):411-6. PubMed ID: 11931672
[TBL] [Abstract][Full Text] [Related]
16. Characterization of procoagulants produced in cell cultures by tests of coagulation.
Zacharski LR; McIntyre OR
Thromb Diath Haemorrh; 1971 Dec; 26(3):493-502. PubMed ID: 5144962
[No Abstract] [Full Text] [Related]
17. The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X.
Branchini A; Baroni M; Burini F; Puzzo F; Nicolosi F; Mari R; Gemmati D; Bernardi F; Pinotti M
J Thromb Haemost; 2015 Aug; 13(8):1468-74. PubMed ID: 26083275
[TBL] [Abstract][Full Text] [Related]
18. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
19. Physiological levels of blood coagulation factors IX and X control coagulation kinetics in an in vitro model of circulating tissue factor.
Tormoen GW; Khader A; Gruber A; McCarty OJ
Phys Biol; 2013 Jun; 10(3):036003. PubMed ID: 23585459
[TBL] [Abstract][Full Text] [Related]
20. III. Instantaneous inhibition by compound 48/80 of tissue factor-initiated extrinsic coagulation is mediated by the downregulation of factor VII activation.
Chu AJ; Wang ZG; Fox MJ
Arch Biochem Biophys; 2000 May; 377(2):357-65. PubMed ID: 10845714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
